Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder Letter Post

170 shareholders holding 57 million shares. Average investor here holds 335,000 shares...??

think about that for a second.... lol.....

Share
New Message
Please login to post a reply